Horizon Therapeutics stock plunges on report FTC is preparing to block Amgen dealThe deal is bid to strengthen Amgen's drug portfolio as it prepares to face several patent expirations for key treatments over the next decade.[Collection]

The deal is bid to strengthen Amgen's drug portfolio as it prepares to face several patent expirations for key treatments over the next decade.https://www.cnbc.com/2023/05/16/horizon-therapeutics-amgen-deal-ftc.html